1.
Southeast Asian J Trop Med Public Health
;
1991 Mar; 22(1): 39-40
Article
in English
| IMSEAR
| ID: sea-34987
ABSTRACT
The immunogenecity of a recombinant yeast-derived hepatitis B vaccine in 25 premature infants who were born to HBsAg negative mothers was studied. The gestational ages were 28-37 weeks and birth weights were 1300-2000 grams. Seroconversion occurred in 22 infants, the anti HBs titers varied between 50 and 13,470 IU/L (Geometric mean titer = 542 IU/L). Seroconversion rate = 88%. The response did not vary with gestational age, birth weight or illness status.
Subject(s)
Hepatitis B Antibodies/biosynthesis , Hepatitis B Surface Antigens/immunology , Hepatitis B Vaccines , Humans , Infant, Newborn , Infant, Premature/immunology , Vaccines, Synthetic/administration & dosage , Viral Hepatitis Vaccines/administration & dosage
2.
Article
in English
| IMSEAR
| ID: sea-42267